Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)
Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC). The update note ...
Ensysce Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results
Secures Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPARGroundbreaking Trial on PF614-MPAR Generates Positive Interim Results SAN DIEGO, CA / ACCESS Newswire / M ...
PharmiWeb10d
Bromelain Market to Surpass USD 755 Mn by 2034 Amid Rising Demand for Natural and Plant-Based Ingredients | TMR Analysis
The global Bromelain Market is experiencing a robust growth phase, driven by the increasing demand for natural enzymes across ...
Ensysce Biosciences to Participate in the 37th Annual ROTH Conference
Detailed price information for Ensysce Biosciences Inc (ENSC-Q) from The Globe and Mail including charting and trades.
Local women raising awareness on a rare disease called Alpha-1
Alpha-1 is a genetic disease that impacts entire families for generations to come that is why the ladies say testing is so ...
C&EN26d
Surface Modification of Poly(dimethylsiloxane) Blood Flow Chambers with a Poly(ethylene glycol) Conjugate and Factor XII Inhibitor
VA Ann Arbor Healthcare System, Ann Arbor, Michigan 48105, United States Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States Department of Surgery, ...